期刊
CANCERS
卷 12, 期 8, 页码 -出版社
MDPI
DOI: 10.3390/cancers12082191
关键词
positron emission tomography; apoptosis; caspase-3; [F-18]ICMT-11; pyrimidoindolone; Michael acceptor
类别
Insufficient apoptosis is a recognised hallmark of cancer. A strategy to quantitatively measure apoptosis in vivo would be of immense value in both drug discovery and routine patient management. The first irreversible step in the apoptosis cascade is activation of the executioner caspase-3 enzyme to commence cleavage of key structural proteins. One strategy to measure caspase-3 activity is Positron Emission Tomography using isatin-5-sulfonamide radiotracers. One such radiotracer is [F-18]ICMT-11, which has progressed to clinical application. This review summarises the design and development process for [F-18]ICMT-11, suggesting potential avenues for further innovation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据